sec filing
NASDAQ · TBPH
Theravance Biopharma, Inc.
Healthcare · Biotechnology
$17.03
Down-$0.01 (-0.06%)
Updated Sep 17, 2026, 5:18 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 895.4M
- P/E ratio
- 54.65
- Dividend yield
- 0.00%
- 52-week range
- $13.08 – $21.03
- Volume
- 461.69K
- Avg. volume
- 424.9K
Price performance
TBPH price history
1M range · 20 trading sessions · Daily adjusted prices
TBPH closed at $17.03 after 20 trading sessions, up 0.24% for the selected period.
- Last close
- $17.03
- Period change
- +0.24%
- Period low
- $16.95
- Period high
- $17.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $17.04 | $17.04 | $17.02 | $17.03 | 461.69K |
| Sep 15, 2026 | $17.02 | $17.06 | $17.02 | $17.04 | 403.74K |
| Sep 14, 2026 | $17.01 | $17.05 | $17.01 | $17.03 | 243.26K |
| Sep 11, 2026 | $17.06 | $17.06 | $17.00 | $17.01 | 426.8K |
| Sep 10, 2026 | $17.05 | $17.05 | $17.00 | $17.02 | 333.93K |
| Sep 9, 2026 | $17.07 | $17.08 | $17.045 | $17.06 | 264.27K |
| Sep 8, 2026 | $17.08 | $17.10 | $17.06 | $17.06 | 251.66K |
| Sep 4, 2026 | $17.255 | $17.255 | $17.07 | $17.08 | 160.55K |
| Sep 3, 2026 | $17.07 | $17.10 | $17.05 | $17.08 | 301.87K |
| Sep 2, 2026 | $17.06 | $17.08 | $17.025 | $17.07 | 566.9K |
| Sep 1, 2026 | $17.08 | $17.08 | $17.02 | $17.03 | 870.67K |
| Aug 31, 2026 | $17.03 | $17.08 | $17.03 | $17.04 | 383.66K |
| Aug 28, 2026 | $17.04 | $17.06 | $17.025 | $17.05 | 414.57K |
| Aug 27, 2026 | $17.04 | $17.105 | $17.03 | $17.04 | 487.33K |
| Aug 26, 2026 | $17.05 | $17.06 | $17.03 | $17.03 | 190.12K |
| Aug 25, 2026 | $17.02 | $17.07 | $17.00 | $17.03 | 332.38K |
| Aug 24, 2026 | $16.99 | $17.03 | $16.97 | $17.01 | 407.28K |
| Aug 21, 2026 | $16.97 | $17.02 | $16.96 | $17.01 | 739.34K |
| Aug 20, 2026 | $16.98 | $17.00 | $16.95 | $16.95 | 205.51K |
| Aug 19, 2026 | $16.96 | $17.00 | $16.96 | $16.99 | 257.86K |
Latest TBPH news
The latest Smart Investors Daily articles mentioning TBPH.
Stock researchResearch & News · SEC Filings
Loading stock research…